A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

T. Ciuleanu, C. M. Tsai, C. J. Tsao, J. Milanowski, D. Amoroso, D. S. Heo, H. J.M. Groen, A. Szczesna, C. Y. Chung, T. Y. Chao, G. Middleton, A. Zeaiter, G. Klingelschmitt, B. Klughammer, N. Thatcher

研究成果: 雜誌貢獻文章同行評審

32 引文 斯高帕斯(Scopus)

指紋

深入研究「A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer」主題。共同形成了獨特的指紋。

Medicine & Life Sciences